Granite Harbor Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
751
+29
+4% +$9.93K 0.11% 106
2026
Q1
$254K Buy
722
+19
+3% +$6.77K 0.11% 109
2025
Q4
$230K Buy
+703
New +$223K 0.1% 114

Other funds holding AMGN

Granite Harbor Advisors's AMGN Position: Q2 2026 in Review

Granite Harbor Advisors increased its Amgen (AMGN) stake by 4% in Q2 2026, buying an estimated $9.93K and bringing the position to 751 shares worth $272K. The position accounts for 0.11% of the portfolio, ranked #106.

Granite Harbor Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Granite Harbor Advisors held 751 shares of Amgen worth $272K as of Q2 2026.
  • Granite Harbor Advisors bought 29 Amgen shares in Q2 2026, an estimated $9.93K.
  • Amgen made up 0.11% of Granite Harbor Advisors's portfolio in Q2 2026, its #106 holding.
  • Granite Harbor Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.